Dialogue Health Technologies Inc.
DLHTF · OTC
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $26 | $25 | $20 | $24 |
| % Growth | 4.1% | 23.9% | -16.2% | – |
| Cost of Goods Sold | $10 | $10 | $9 | $11 |
| Gross Profit | $15 | $14 | $11 | $12 |
| % Margin | 59.7% | 57.4% | 54.7% | 52.2% |
| R&D Expenses | $4 | $3 | $3 | $3 |
| G&A Expenses | $13 | $10 | $8 | $13 |
| SG&A Expenses | $17 | $14 | $11 | $16 |
| Sales & Mktg Exp. | $4 | $4 | $3 | $3 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $21 | $17 | $14 | $19 |
| Operating Income | -$5 | -$3 | -$3 | -$7 |
| % Margin | -20.9% | -12.8% | -16.9% | -28.7% |
| Other Income/Exp. Net | $1 | $1 | -$1 | $0 |
| Pre-Tax Income | -$5 | -$3 | -$4 | -$6 |
| Tax Expense | $1 | $0 | $0 | -$1 |
| Net Income | -$6 | -$3 | -$5 | -$6 |
| % Margin | -22.5% | -10.8% | -22.8% | -25.4% |
| EPS | -0.086 | -0.04 | -0.068 | -0.091 |
| % Growth | -115.6% | 41.3% | 25.1% | – |
| EPS Diluted | -0.086 | -0.04 | -0.068 | -0.091 |
| Weighted Avg Shares Out | 67 | 67 | 66 | 66 |
| Weighted Avg Shares Out Dil | 67 | 67 | 66 | 66 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$4 | -$2 | -$2 | -$6 |
| % Margin | -15.7% | -7.6% | -9.3% | -23.4% |